MedPath
TGA Product

NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray

Product approved by Therapeutic Goods Administration (AU)

Basic Information

NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray

Regulatory Information

77112

February 14, 2001

Medicine

Medicine

RE

Active

Company Information

Active Ingredients

Detailed Information

Summary

https://medical-cdn.nocode.com/drug_tga/36e0ed61b08895e13bdb305f0df06cd9.pdf

© Copyright 2025. All Rights Reserved by MedPath